PCTC
IBB icon

Perkins Coie Trust Company’s iShares Biotechnology ETF IBB Stock Holding History

Perkins Coie Trust Company’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.72M Sell
19,544
-311
-2% -$53.5K 0.62% 40
2026
Q1 		$3.35M Buy
19,855
+180
+0.9% +$30.8K 0.64% 43
2025
Q4 		$3.32M Sell
19,675
-741
-4% -$120K 0.62% 44
2025
Q3 		$2.95M Sell
20,416
-703
-3% -$96K 0.55% 48
2025
Q2 		$2.67M Sell
21,119
-1,493
-7% -$183K 0.46% 49
2025
Q1 		$2.89M Sell
22,612
-525
-2% -$71.2K 0.66% 50
2024
Q4 		$3.06M Sell
23,137
-1,309
-5% -$184K 0.67% 47
2024
Q3 		$3.56M Sell
24,446
-738
-3% -$107K 0.79% 43
2024
Q2 		$3.46M Buy
25,184
+83
+0.3% +$11.1K 0.8% 41
2024
Q1 		$3.44M Buy
25,101
+1,592
+7% +$217K 0.81% 43
2023
Q4 		$3.19M Buy
23,509
+3,033
+15% +$370K 0.81% 41
2023
Q3 		$2.5M Buy
+20,476
New +$2.6M 0.71% 46

Other funds holding IBB

WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
CA
Cumberland Advisors Sarasota, Florida $284M AUM 27.11% 1-Year Est. Return
FNFDCM
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

Perkins Coie Trust Company's IBB Position: Q2 2026 in Review

Perkins Coie Trust Company reduced its iShares Biotechnology ETF (IBB) stake by 1.6% in Q2 2026, selling an estimated $53.5K and leaving 19,544 shares worth $3.72M. The position accounts for 0.62% of the portfolio, ranked #40.

Perkins Coie Trust Company first reported a position in IBB in Q3 2023 and has held it in 12 quarters since. 285 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Perkins Coie Trust Company held 19,544 shares of iShares Biotechnology ETF worth $3.72M as of Q2 2026.
  • Perkins Coie Trust Company sold 311 iShares Biotechnology ETF shares in Q2 2026, an estimated $53.5K.
  • iShares Biotechnology ETF made up 0.62% of Perkins Coie Trust Company's portfolio in Q2 2026, its #40 holding.
  • Perkins Coie Trust Company first reported a position in iShares Biotechnology ETF in Q3 2023 and has held it in 12 quarters since.
  • 285 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Perkins Coie Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.